GILEAD SCIENCES, INC.
CIK
882095
Location
FOSTER CITY, CA
Portfolio Value
Mid
$2,117,784,503
Diversification
Highly concentrated
Filing Date
Global Rank
#1,156
/ 8,603
▲ 57
· as of Mar 2026
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
+28.8%
Period ended 3 months ago
Filed May 8, 2026 · 2mo
6 quarters · since Dec 2024
Clone Performance
Feb 2025–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+68.9%
SPY
+24.0%
Annualised alpha
+28.9%
Max drawdown
−25.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
6 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
36.4%
−0.9 pts
Top 5
99.7%
+1.7 pts
Top 10
100.0%
0.0 pts
HHI
2,953
Highly concentrated+264
Portfolio Trend
6 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $2,117,784,503 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| XLO | Xilio Therapeutics, Inc. | −8,455,062 | 650,389 | $5,469,771 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
6 positions ·
$2,117,784,503 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ACLX |
Arcellx, Inc.
Healthcare
|
Held | 6,720,803 | $771,682,600 | 36.44% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Held | 31,424,760 | $678,774,816 | 32.05% | |
| LKFT |
Lakefront Biotherapeutics NV
Healthcare
|
Held | 16,707,477 | $501,224,310 | 23.67% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
Held | 4,505,391 | $125,024,600 | 5.90% | |
| KYTX |
Kyverna Therapeutics, Inc.
Healthcare
|
Held | 4,126,119 | $35,608,406 | 1.68% | |
| XLO |
Xilio Therapeutics, Inc.
Healthcare
|
Reduced | 650,389 | $5,469,771 | 0.26% |